ArborGen (RUBNF) Stock Price, News & Analysis

Company Overview

ArborGen is a company specializing in the development and production of advanced tree seedlings for the forestry, biomass and bioenergy markets. The company applies tree breeding, genetic improvement and vegetative propagation techniques to deliver seedlings with enhanced growth characteristics, disease resistance and wood quality. ArborGen’s product portfolio includes both conifer and hardwood seedlings, tailored for use in commercial timber plantations and restoration projects.

Headquartered in Summerville, South Carolina, ArborGen operates nurseries and research facilities across multiple geographies, including the United States, Brazil, New Zealand and Australia. These locations support regionally adapted breeding programs that address local market needs and growing conditions. Through its global supply chain, ArborGen provides seedlings to large forest product companies, independent growers and landowners.

In addition to seedling production, ArborGen offers technical services such as silvicultural guidance, plantation design support and genetic testing. The company’s ongoing research partnerships focus on genomics, pest and disease mitigation, and productivity improvements aimed at advancing sustainable forestry practices. ArborGen’s emphasis on innovation and quality positions it as a key supplier for intensively managed forest operations worldwide.

Key Stats

• Today's Range: $0.03 to $0.03
• 50-Day Range: $0.03 to $0.05
• 52-Week Range: $0.03 to $0.07
• Volume: 1,060 shs
• Average Volume: 3,425 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Basic Materials
• Industry: Lumber & Wood Production
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RUBNF
• CIK: N/A
• Web: www.rubicon-nz.com
• Phone: (649) 356-9800
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A